Heme Oxygenase Inhibition by α‐(1H‐Imidazol‐1‐yl)‐ω‐phenylalkanes: Effect of Introduction of Heteroatoms in the Alkyl Linker
暂无分享,去创建一个
G. Roman | J. Vlahakis | K. Nakatsu | W. Szarek | D. Vukomanovic | C. Lazăr
[1] D. Stevenson,et al. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins , 2011, Journal of Perinatology.
[2] A. Józkowicz,et al. Heme oxygenase-1 in tumor biology and therapy. , 2010, Current drug targets.
[3] Z. Jia,et al. Heme Oxygenase Inhibition by 2‐Oxy‐substituted 1‐Azolyl‐4‐phenylbutanes: Effect of Variation of the Azole Moiety. X‐Ray Crystal Structure of Human Heme Oxygenase‐1 in Complex with 4‐Phenyl‐1‐(1H‐1,2,4‐triazol‐1‐yl)‐2‐butanone † , 2010, Chemical biology & drug design.
[4] Jie Su,et al. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. , 2009, Cancer research.
[5] Z. Jia,et al. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring. , 2009, Bioorganic & medicinal chemistry.
[6] R. Kinobe,et al. Inhibitors of the heme oxygenase - carbon monoxide system: on the doorstep of the clinic? , 2008, Canadian journal of physiology and pharmacology.
[7] Alexander D. MacKerell,et al. Inhibition of the bacterial heme oxygenases from Pseudomonas aeruginosa and Neisseria meningitidis: novel antimicrobial targets. , 2007, Journal of medicinal chemistry.
[8] R. Kinobe,et al. Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring. , 2007, Bioorganic & medicinal chemistry.
[9] D. Stevenson,et al. Pharmacology Review: Tin Mesoporphyrin for the Prevention of Severe Neonatal Hyperbilirubinemia , 2007 .
[10] R. Kinobe,et al. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors. , 2006, Journal of medicinal chemistry.
[11] R. Kinobe,et al. Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors. , 2005, Bioorganic & medicinal chemistry letters.
[12] Y. Itoyama,et al. Heme catabolism and heme oxygenase in neurodegenerative disease. , 2004, Antioxidants & redox signaling.
[13] T. Hegyi,et al. Tin-mesoporphyrin in the Treatment of Severe Hyperbilirubinemia in a Very-low-birth-weight Infant , 2003, Journal of Perinatology.
[14] H. Maeda,et al. Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity. , 2002, Bioconjugate chemistry.
[15] D. Stevenson,et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[16] Abraham Nudelman,et al. NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities. , 1997, The Journal of organic chemistry.
[17] D K Stevenson,et al. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. , 1995, Canadian journal of physiology and pharmacology.
[18] F. Gasparrini,et al. A general procedure for the selective oxidation of sulfides to sulfoxides by nitric acid: tetrabromoaurate(III) catalyst in a biphasic system , 1990 .
[19] M. Maines. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] S. Brimijoin,et al. Synthesis of alkylene linked bis-THA and alkylene linked benzyl-THA as highly potent and selective inhibitors and molecular probes of acetylcholinesterase , 1997 .
[21] D K Stevenson,et al. Heme oxygenase activity as measured by carbon monoxide production. , 1988, Analytical biochemistry.